Figure 1
Flow diagram of participants included in the analysis with initial and repeated elevated measures of blood pressure and HbA1c.
Table 1
Cohort Demographics.
| Elevated blood Pressure | Elevated blood sugar | Overall population | |
|---|---|---|---|
| Characteristic | N = 8711 | N = 1,1511 | N = 18,0271 |
| Age | 58 (45, 68) | 60 (51, 68) | 37 (23, 56) |
| Age categories | |||
| 15–24 | 36 (4.1%) | 26 (2.3%) | 4,967 (28%) |
| 25–44 | 172 (20%) | 123 (11%) | 6,000 (33%) |
| 45–64 | 374 (43%) | 628 (55%) | 4,593 (25%) |
| 65+ | 289 (33%) | 374 (32%) | 2,467 (14%) |
| Sex | |||
| Male | 277 (32%) | 196 (17%) | 5,800 (32%) |
| Female | 594 (68%) | 955 (83%) | 12,227 (68%) |
| BMI | 30 (25, 36) | 33 (28, 38) | 26 (22, 32) |
| Systolic BP | 147 (141, 159) | 125 (114, 138) | 114 (103, 125) |
| Diastolic BP | 91 (82, 97) | 76 (68, 83) | 70 (63, 78) |
| HbA1c % | 5.80 (5.50, 6.20) | 7.10 (6.60, 10.20) | 5.70 (5.40, 6.00) |
[i] 1 Median (IQR); n (%).
Figure 2
Distribution and correlation of blood pressure and HbA1c with blood glucose measures done at initial screening and confirmatory follow-up visit.
Figure 3
Predictions from a logistic regression model of the relationship between initial blood pressure and HbA1c glucose and the probability of having elevated blood pressure or blood glucose during the confirmatory follow-up visit.